Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

被引:0
|
作者
Amir, E. [1 ]
Broom, R. [1 ]
Freedman, O. [1 ]
Ooi, W. S. [1 ]
Done, S. [2 ]
Gianfelice, D. [3 ]
Barth, D. [1 ]
Kahn, H. [4 ]
Clemons, M. [1 ]
机构
[1] Princess Margaret Hosp, Div Hematol & Med Oncol, Toronto, ON M4X 1K9, Canada
[2] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
[3] Univ Hlth Network, Dept Intervent Radiol, Toronto, ON, Canada
[4] Sunnybrook Med Ctr, Dept Pathol, Toronto, ON, Canada
关键词
Breast Cancer; Estrogen Receptor; Progesterone Receptor; Bone Metastasis; Receptor Status;
D O I
10.1186/bcr2310
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S18 / S18
页数:1
相关论文
共 50 条
  • [21] Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis
    Ibrahim, M. F. K.
    Mazzarello, S.
    Shorr, R.
    Vandermeer, L.
    Jacobs, C.
    Hilton, J.
    Hutton, B.
    Clemons, M.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2205 - 2213
  • [22] Positive Bone Marrow Biopsy Is Associated with a Decreased Disease-Free Survival in Patients with Operable Breast Cancer
    Lucio Fortunato
    Alessandra Mascaro
    Alfonso Baldi
    Massimo Farina
    Giuliana Cortese
    Maria Antonietta Ventrone
    Mostafà Amini
    Carlo Vitelli
    Annals of Surgical Oncology, 2009, 16 : 3010 - 3019
  • [23] Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients
    Coombes, RC
    De Bella, MT
    Tripuraneni, G
    Zaidi, A
    Anwer, S
    Stephens, DA
    Ward, B
    Sinnett, HD
    Slade, MJ
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 1) : S5 - S6
  • [24] Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients
    RC Coombes
    MT De Bella
    G Tripuraneni
    A Zaidi
    S Anwer
    DA Stephens
    B Ward
    HD Sinnett
    MJ Slade
    Breast Cancer Research, 7
  • [25] Discordance of Biomarker Expression Profile between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis in Preoperative Core Needle Biopsy
    Marletta, Stefano
    Giorlandino, Alexandra
    Cavallo, Enrico
    Venti, Michele Dello Spedale
    Leone, Giorgia
    Tranchina, Maria Grazia
    Gullotti, Lucia
    Bonanno, Claudia Lucia
    Spoto, Graziana
    Falzone, Giusi
    Tornabene, Irene
    Trovato, Carmelina
    Baron, Marco Maria
    Di Mauro, Giuseppe
    Falsaperna, Lucia
    Angelico, Giuseppe
    Pafumi, Sarah
    Rizzo, Antonio
    DIAGNOSTICS, 2024, 14 (03)
  • [26] Changes in Estrogen Receptor, Progesterone Receptor and Her-2/neu Status with Time: Discordance Rates Between Primary and Metastatic Breast Cancer
    Broom, Reuben J.
    Tang, Patricia A.
    Simmons, Christine
    Bordeleau, Louise
    Mulligan, Anna Marie
    O'Malley, Frances P.
    Miller, Naomi
    Andrulis, Irene L.
    Brenner, Darren M.
    Clemons, Mark J.
    ANTICANCER RESEARCH, 2009, 29 (05) : 1557 - 1562
  • [27] A Representative Clinical Course of Progression, with Molecular Insights, of Hormone Receptor-Positive, HER2-Negative Bone Metastatic Breast Cancer
    Magno, Elizabeth
    Bussard, Karen M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [28] Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis
    Kinoe, Hiroko
    Yamanouchi, Kosho
    Kuba, Sayaka
    Morita, Michi
    Sakimura, Chika
    Kanetaka, Kengo
    Takatsuki, Mitsuhisa
    Abe, Kuniko
    Yano, Hiroshi
    Matsumoto, Megumi
    Otsubo, Ryota
    Hayashida, Naomi
    Nagayasu, Takeshi
    Eguchi, Susumu
    JOURNAL OF BUON, 2018, 23 : S60 - S66
  • [29] Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow
    Abreu, A. P. S.
    Milani, C.
    Katayama, M. L. H.
    Barbosa, E. M.
    Gomes da Fonseca, L.
    Goes, I. C. S.
    Brentani, M. M.
    Koike Folgueira, M. A. A.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2008, 23 (04) : 219 - 224
  • [30] Prognostic significance of laminin, laminin receptor, and bone marrow micrometastases in breast cancer patients - Are these markers of aggressive behavior and metastatic potential?
    Molino, A
    Pedersini, R
    Micciolo, R
    Frisinghelli, M
    Giovannini, M
    Pavarana, M
    Santo, A
    Colato, C
    Piubello, Q
    Cetto, GL
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (04) : 311 - 318